New Release of NCCN Guidelines for Patients: Colon Cancer; Updated NCCN Guidelines for Patients: Prostate Cancer
New NCCN Guidelines for Patients™: Colon Cancer and Updated NCCN Guidelines for Patients™: Prostate Cancer are now available on-line at NCCN.com. The same authoritative source referenced by physicians and other health care professionals is now written for and available to patients and their caregivers.
FORT WASHINGTON, PA —In order to provide people with cancer and their caregivers state-of-the-art treatment information in patient-friendly language, the National Comprehensive Cancer Network® (NCCN®) has developed two new publications: a new release of the NCCN Guidelines for Patients™: Colon Cancer and an update to the NCCN Guidelines for Patients™: Prostate Cancer. The guidelines provide a framework to help people with cancer talk with their physician about the best treatment options.
According to the 2012 annual report from the the American Cancer Society (ACS), the Centers for Disease Control and Prevention (CDC), the National Cancer Institute (NCI), and the North American Association of Central Cancer Registries (NAACCR) (Seigel, Naishadham, & Jemal, 2012), colon cancer is the fourth most common cancer in the United States. The newly released NCCN Guidelines for Patients™: Colon Cancer include a treatment guide covering the different stages of colon cancer from early detection and diagnosis throughout treatment, across the entire continuum of care. The guidelines describe tests and treatment options for colon cancer, along with treatment side effects. A thorough glossary is included to aid patients with medical terminology. These guidelines suggest the best practice for colon cancer care and support enrollment into clinical trials when appropriate.
Prostate cancer is a complex disease; unfortunately there is a dearth of sound data to support treatment recommendations. NCCN Guidelines for Patients™: Prostate Cancer cover several variables (including life expectancy, disease characteristics, predicted outcomes, and patient preferences) that should be considered by the patient and the physician in tailoring prostate cancer therapy to the individual patient. The guidelines provide information that will help people with prostate cancer and their friends and family understand the cancer, and further to help them talk with their cancer care team about the best treatment options. In particular, the guidelines give treatment recommendations based on the characteristics of the cancer possible side effects of treatments, and a side-by-side comparison of the main benefits and disadvantages of the treatments for prostate cancer.
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) are the most widely used guidelines in oncology practice; physicians around the globe use the NCCN Guidelines when determining appropriate cancer treatment for their patients. The NCCN Guidelines for Patients™ present the same information that physicians use when making treatment decisions for people with cancer, and provide it in an easy-to-understand format.
The NCCN Guidelines for Patients™: Colon Cancer and Prostate Cancer are available free of charge on-line at NCCN.com and NCCN.org. The updated NCCN Guidelines for Patients™: Prostate Cancer is also available in print booklet format. To request a hard copy of this resource, e-mail email@example.com.
Through the support of the NCCN Foundation, NCCN now offers a library of nine NCCN Guidelines for Patients™, including those on breast, colon, ovarian, non-small cell lung and prostate cancers, as well as chronic myelogenous leukemia, malignant pleural mesothelioma, melanoma, and multiple myeloma. All of these Guidelines are available free of charge at NCCN.com, which also features informative articles for patients and caregivers. These guidelines are also featured on NCCN.org.
About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 25 of the world's leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers. The primary goal of all NCCN initiatives is to improve the quality, effectiveness, and efficiency of oncology practice so patients can live better lives. For more information, visit NCCN.org.
The NCCN Member Institutions are:
- Fred & Pamela Buffett Cancer Center at The Nebraska Medical Center
- City of Hope Comprehensive Cancer Center
- Dana-Farber/Brigham and Women's Cancer Center
Massachusetts General Hospital Cancer Center
- Duke Cancer Institute
- Fox Chase Cancer Center
- Huntsman Cancer Institute at the University of Utah
- Fred Hutchinson Cancer Research Center / Seattle Cancer Care Alliance
- The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University
- Mayo Clinic Cancer Center
- Memorial Sloan Kettering Cancer Center
- Moffitt Cancer Center
- The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
- Roswell Park Cancer Institute
- Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
- St. Jude Children's Research Hospital/The University of Tennessee Health Science Center
- Stanford Cancer Institute
- University of Alabama at Birmingham Comprehensive Cancer Center
- UC San Diego Moores Cancer Center
- UCSF Helen Diller Family Comprehensive Cancer Center
- University of Colorado Cancer Center
- University of Michigan Comprehensive Cancer Center
- The University of Texas MD Anderson Cancer Center
- Vanderbilt-Ingram Cancer Center
- Yale Cancer Center/Smilow Cancer Hospital